Here are 10 things to know about SII s Covishield vaccine from package insert & factsheet
The package insert and factsheet the comes with the vaccine includes information on indications and usage, dosage strength, clinical efficacy, contraindications, risks and benefits, and use in specific populations. January 13, 2021 / 03:25 PM IST
Serum Institute of India (SII), which is rolling out its Covid-19 vaccine Covishield has released the package insert and fact sheet. While the package insert is for medical practitioners and hospitals, the fact sheet is for vaccine recipients. The package insert and factsheet comes with the vaccine, includes information on indications and usage, dosage strength, clinical efficacy, contraindications, risks and benefits, and use in specific populations. Here are some important things about the Covishield vaccine that was approved in India for restricted use in an emergency situation.
Covishield FAQ: Serum Institute answers all your queries ahead of COVID-19 vaccination drill
Representational Image
Ahead of the nationwide inoculation exercise against coronavirus disease (COVID-19) across India, the Serum Institute has issued a fact-sheet to answer all the Frequently Asked Questions (FAQs) that vaccine beneficiaries might have in preparation of the drill.
As with any other necessary fact-sheets of the sort, it contains information to help you understand the risks and benefits of the vaccine, which most citizens are set to receive soon as the long-promised cure against the disease caused by SARS-CoV-2.
The Covishield vaccines have already reached some states. Till 4 PM, about 54,72,000 doses were received by the states and Union Territories, the Union Ministry of Health and Family Welfare had said earlier on this day. By January 14, 100 per cent doses will be received.